Tag: Prescription Drugs
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Oral Propranolol Seems Safe for Infantile Hemangioma
Good safety profile for children with infantile hemangioma with no prespecified underlying disease
Galcanezumab Beats Placebo for Episodic Migraine
Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
Elevated HbA1c Usually Leads to Prompt Tx Start, Intensification
Within 6 months of elevated HbA1c, rate of initiation 63 percent, rate of intensification 82 percent
Certolizumab Looks Promising for Moderate-to-Severe Psoriasis
Higher-dose certolizumab (400 mg) better at cutting symptoms than low-dose (200 mg)
Increase in Tx Candidates With 2017 Hypertension Guidelines
Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths
Dupilumab Reduces Rate of Severe Asthma Exacerbations
And, add-on dupilumab reduces glucocorticoid dose in patients with glucocorticoid-treated asthma
TNFi Exposure In Utero Does Not Up Serious Infection Risk
No increased risk of serious infection among RA offspring versus non-TNFi exposed or control
Increase in Pediatric ADHD Meds Exposures from 2000 to 2011
Intentional meds exposure most often reported among teens, accounting for half of teen exposure
Semaglutide Found to Be Effective Against Type 2 Diabetes
The once-weekly glucagon-like peptide 1 receptor agonist cuts HbA1c, body weight
